US 8709430
Cancer treatment kits comprising therapeutic antibody conjugates that bind to aminophospholipids
granted A61KA61K39/395A61K47/6835
Quick answer
US patent 8709430 (Cancer treatment kits comprising therapeutic antibody conjugates that bind to aminophospholipids) held by The Board of Regents of the University of Texas System expires Mon Apr 24 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Board of Regents of the University of Texas System
- Grant date
- Tue Apr 29 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 24 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 32
- CPC classes
- A61K, A61K39/395, A61K47/6835, A61K47/6849, A61K49/04